SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-03-020319
Filing Date
2003-07-17
Accepted
2003-07-16 18:36:27
Documents
2
Period of Report
2003-07-16
Items
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT d8k.htm 8-K 10735
3 PRESS RELEASE dex991.htm EX-99.1 10571
  Complete submission text file 0001193125-03-020319.txt   23012
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 03790029
SIC: 8731 Services-Commercial Physical & Biological Research